Virus Research 2011-01-01

HIV-1 clade C envelopes obtained from late stage symptomatic Indian patients varied in their ability towards relative CD4 usages and sensitivity to CCR5 antagonist TAK-779

Lavina Gharu, Rajesh Ringe, Jayanta Bhattacharya, Lavina Gharu, Rajesh Ringe, Jayanta Bhattacharya, Lavina Gharu, Rajesh Ringe, Jayanta Bhattacharya

Index: Virus Res. 158(1-2) , 216-24, (2011)

Full Text: HTML

Abstract

Highlights ► Compared envelopes with expanded coreceptor tropism with those that are strictly CCR5 using for their capacity to utilize CD4 and CCR5. ► Low CD4 dependent envelopes infect primary cells better than those that required optimum CD4 for entry ► No association between low CD4 usage and sensitivity to TAK-779 ► Envelopes with low CD4 usage showed relative resistance to T-20 ► Data throw important insight in disease transmission in late stage in context of subtype C HIV-1 variants.

Related Compounds

  • TAK-779

Related Articles:

Effects of a calcineurin inhibitor, FK506, and a CCR5/CXCR3 antagonist, TAK-779, in a rat small intestinal transplantation model.

2011-07-01

[Transpl. Immunol. 25(1) , 49-55, (2011)]

Evolution of CCR5 antagonist resistance in an HIV-1 subtype C clinical isolate.

2010-12-01

[J. Acquir. Immune Defic. Syndr. 55(4) , 420-7, (2010)]

Synthesis of [19, 35, 36-(13)C(3)]-labeled TAK779 as a molecular probe.

2009-08-15

[Bioorg. Med. Chem. 17(16) , 5769-74, (2009)]

HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug.

2012-01-01

[J. Virol. 86(2) , 1119-28, (2012)]

C-C chemokine receptor type 5 (CCR5) utilization of transmitted and early founder human immunodeficiency virus type 1 envelopes and sensitivity to small-molecule CCR5 inhibitors.

2010-12-01

[J. Gen. Virol. 91(Pt 12) , 2965-73, (2010)]

More Articles...